PANTHER: Should Clopidogrel Become the ' New Aspirin ' in CAD? PANTHER: Should Clopidogrel Become the ' New Aspirin ' in CAD?

The PANTHER meta-analysis of trials comparing aspirin with clopidogrel or ticagrelor as antiplatelet monotherapy in coronary artery disease patients suggest that P2Y12 inhibitor therapy is more effective.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news